RGS
Click for more information
0.00% 12.0¢ regeneus ltd

News: Regeneus in commercialisation discussions, reduces costs in review

  1. Proactive
    clock Created with Sketch.
    24/11/14
    16:40
    Post #: 14343686

    Apart from making significant cost reductions, Regeneus is in discussions with potential partners about licensing, development and distribution of its allogeneic stem cell products CryoShot and Progenza.

    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS High grade drill results discovered at CODA North
right-arrow Created with Sketch.
NEWS Share Purchase Plan by robotic technology company now complete
right-arrow Created with Sketch.
NEWS Experienced CEO appointed to Indiana Resources
right-arrow Created with Sketch.
NEWS MTM and Indium form strategic collaboration for recovering Gallium and Germanium
right-arrow Created with Sketch.
NEWS Significant milestone reached in Zimbabwe's oil and gas exploration industry as Invictus Energy moves closer to execution
right-arrow Created with Sketch.
MKG Encouraging results for Raiden as Pegmatite extensions confirmed
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.